Safety of Ertapenem in Beta-lactam Allergic Patients.
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess cross-reactivity and tolerability of ertapenem in
patients with IgE-mediated allergy to at least one beta-lactam molecule.